Scarica l'app Stockscreener
13.00
7.08%
-0.99
Precedente Chiudi:
$13.99
Aprire:
$13.8
Volume 24 ore:
276.10K
Relative Volume:
3.93
Capitalizzazione di mercato:
$538.58M
Reddito:
-
Utile/perdita netta:
-
Rapporto P/E:
-
EPS:
-
Flusso di cassa netto:
-
1 W Prestazione:
-5.04%
1M Prestazione:
+0.00%
6M Prestazione:
+0.00%
1 anno Prestazione:
+0.00%
Intervallo 1D:
$12.92
$14.32
Intervallo di 1 settimana:
$12.92
$15.38
Portata 52W:
$12.92
$18.84
Maplight Therapeutics Inc Stock (MPLT) Company Profile
Nome
Maplight Therapeutics Inc
Settore
Industria
Telefono
-
Indirizzo
-
Confronta MPLT con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
MPLT
Maplight Therapeutics Inc
|
13.00 | 610.54M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
424.00 | 108.28B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
761.45 | 79.44B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
434.23 | 57.65B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
906.74 | 56.58B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
206.93 | 42.39B | 447.02M | -1.18B | -906.14M | -6.1812 |
Maplight Therapeutics Inc Stock (MPLT) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-11-21 | Iniziato | Jefferies | Buy |
| 2025-11-21 | Iniziato | Leerink Partners | Outperform |
| 2025-11-21 | Iniziato | Morgan Stanley | Overweight |
| 2025-11-21 | Iniziato | Stifel | Buy |
Maplight Therapeutics Inc Borsa (MPLT) Ultime notizie
MapLight Therapeutics Closes Successful IPO and Private Placement - MSN
MapLight Therapeutics stock rating reiterated at Overweight by Morgan Stanley - Investing.com Canada
MapLight Therapeutics initiated with a Buy at Stifel - MSN
Jefferies & Co Initiates Coverage on MapLight Therapeutics With Buy Rating, $32 Price Target - MarketScreener
Morgan Stanley Initiates MapLight Therapeutics at Overweight With $34 Price Target - MarketScreener
MPLT Analyst Forecasts - Quiver Quantitative
MapLight Therapeutics stock initiated with Outperform rating by Leerink Partners - Investing.com Canada
Buy Recommendation for MapLight Therapeutics: Promising Pipeline and Market Potential - TipRanks
Promising Investment in MapLight Therapeutics: Buy Rating Backed by Strategic Positioning and Strong Financials - TipRanks
MapLight Therapeutics, Inc.: Revenue and Earnings Analysts Forecasts Revisions | MPLT | US56565P1030 - MarketScreener
MapLight Therapeutics stock initiated with Buy rating at Jefferies By Investing.com - Investing.com Canada
MapLight Therapeutics stock initiated with Buy rating by Stifel - Investing.com Canada
Morgan Stanley initiates MapLight Therapeutics stock with Overweight rating By Investing.com - Investing.com Canada
MapLight Therapeutics, Inc. (MPLT) Balance Sheet - Yahoo! Finance Canada
MapLight Therapeutics, Inc. (MPLT) Latest Press Releases & Corporate News - Yahoo! Finance Canada
MapLight Therapeutics, Inc. share price - Capital.com
Timothy John Garnett Net Worth (2025) - GuruFocus
Erin Pennock Foff Net Worth (2025) - GuruFocus
Anatol Kreitzer Net Worth (2025) - GuruFocus
Vishwas Setia Net Worth (2025) - GuruFocus
Insiders Scoop Up Shares of This Biotech IPO, Energy Giant, and More - AOL.com
MapLight Therapeutics, Inc. (MPLT) stock major holders - Yahoo Finance UK
Potential Bristol Myers rival MapLight seeks $250M in U.S. IPO - MSN
Maplight Therapeutics (MPLT) Stock Trends and Sentiment 2025 - MarketBeat
Long term debt to total assets ratio of MapLight Therapeutics, Inc. – NASDAQ:MPLT - TradingView
Maplight Therapeutics (MPLT) 10K Form and SEC Filings 2025 - MarketBeat
Maplight Therapeutics (MPLT) Stock Chart and Price History 2025 - MarketBeat
Evommune nabs $150M in IPO amid federal shutdown - BioPharma Dive
Maplight Therapeutics (MPLT) Competitors and Alternatives 2025 - MarketBeat
MapLight Therapeutics, Inc. (MPLT) Stock Major Holders - Yahoo! Finance Canada
MapLight Therapeutics, Inc. (MPLT) stock historical prices and data - Yahoo Finance UK
Operating cash flow per share of MapLight Therapeutics, Inc. – BOATS:MPLT - TradingView
Long term debt to total assets ratio of MapLight Therapeutics, Inc. – BOATS:MPLT - TradingView
MapLight Therapeutics, Inc. Cash Flow – BOATS:MPLT - TradingView
MapLight Therapeutics, Inc. (MPLT) options chain - Yahoo Finance UK
Net current asset value per share of MapLight Therapeutics, Inc. – NASDAQ:MPLT - TradingView
Sergey Brin Nonprofit Gets $261 Million Lift in MapLight IPO - MSN
U.S. IPO Weekly Recap: Navan Slips, And Medline Joins The Pipeline To Close Out October - Seeking Alpha
Finance Watch: MapLight Brings US Biopharma IPO Tally To 11 In 2025 - Citeline News & Insights
Major Investment Alert: A S Novo’s Multi-Million Dollar Bet on MapLight Therapeutics! - TipRanks
Drug developer Evommune to go public next week, following MapLight's successful IPO - The Business Journals
MapLight Therapeutics completes $296 million IPO on nasdaq - Investing.com
Inflammation biotech Evommune prices IPO after MapLight's $250M debut - Fierce Biotech
Catalyst4, Inc. Makes a Major Move with a Massive Stock Purchase in MapLight Therapeutics! - TipRanks
MapLight Therapeutics, Inc. (MPLT) Latest Stock News & Headlines - Yahoo! Finance Canada
MapLight Therapeutics, Inc. (MPLT) Stock Forum & Discussion - Yahoo! Finance Canada
MapLight Therapeutics, Inc. (MPLT) Interactive Stock Chart - Yahoo! Finance Canada
MapLight Therapeutics completes $296 million IPO on nasdaq By Investing.com - Investing.com Nigeria
MapLight Therapeutics Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares - The Manila Times
MapLight Therapeutics Announces Closing of Initial Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares - Benzinga
Cash from investing activities of MapLight Therapeutics, Inc. – NASDAQ:MPLT - TradingView
Maplight Therapeutics Inc Azioni (MPLT) Dati Finanziari
Non sono disponibili dati finanziari per Maplight Therapeutics Inc (MPLT). Controlla altri titoli per ulteriori informazioni.
Reddito
Reddito netto
Flusso di cassa
EPS
2.13%
4.32%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):